CVRx receives FDA approval for expanded labeling of Barostim

December 27, 2023

https://www.globenewswire.com/news-release/2023/12/26/2801082/0/en/CVRx-receives-FDA-approval-for-expanded-labeling-of-Barostim.html

MINNEAPOLIS, Dec. 26, 2023 (GLOBE NEWSWIRE) — CVRx, Inc. (NASDAQ:CVRX) (“CVRx”), a commercial-stage medical device company, announced today that the U.S. Food and Drug Administration (FDA) has approved revised Instructions For Use (IFU) for Barostim incorporating key long-term clinical data from the BeAT-HF randomized clinical trial.

Read more at globenewswire.com

Related news for (CVRX)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.